Asian Scientist (Jul. 30, 2013) – Lumenis Ltd. and Visonix have announced a strategic agreement for Lumenis to distribute the Visionix ophthalmic and optometric diagnostics product line in China.
The partnership will allow Lumenis to build on its presence in the Asia Pacific region and further expand its product offering.
“We are delighted to partner with Visionix; and to offer their innovative, intuitive and cost-effective solutions to our ophthalmology and optometry customers in China,” said Qiying Zhai, President of Lumenis Asia-Pacific.
Lumenis offers the industry’s most extensive and clinically-proven line of ophthalmic lasers to preserve and improve vision. The company’s lasers are now a standard tool to treat many sight-threatening diseases, including diabetic retinopathy, glaucoma, and secondary cataracts.
Visionix is the pioneer of the world’s first true wavefront based refraction line. The Visionix ophthalmic and optometric diagnostic products that Lumenis will be distributing in China include phoropters, wavefront aberometers, visual field analyzer slit lamps and lens edging system.
“We are very excited to embark on this strategic alliance with Lumenis as our two companies’ product lines complement each other perfectly,” said Dr. Marc Abitbol, President and CEO of Visionix.
——
Source: Lumenis.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
